BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8856154)

  • 1. Bradykinin and nitric oxide in infectious disease and cancer.
    Maeda H; Akaike T; Wu J; Noguchi Y; Sakata Y
    Immunopharmacology; 1996 Jun; 33(1-3):222-30. PubMed ID: 8856154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic mechanisms induced by microbial proteases in microbial infections.
    Maeda H; Yamamoto T
    Biol Chem Hoppe Seyler; 1996 Apr; 377(4):217-26. PubMed ID: 8737987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kallikrein-kinin in infection and cancer.
    Maeda H; Wu J; Okamoto T; Maruo K; Akaike T
    Immunopharmacology; 1999 Sep; 43(2-3):115-28. PubMed ID: 10596842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of vascular permeability upon serratial infection: activation of Hageman factor--kallikrein--kinin cascade.
    Matsumoto K; Yamamoto T; Kamata R; Maeda H
    Adv Exp Med Biol; 1986; 198 Pt B():71-8. PubMed ID: 2880483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of bradykinin in microbial infection: enhancement of septicemia by microbial proteases and kinin.
    Maeda H; Akaike T; Sakata Y; Maruo K
    Agents Actions Suppl; 1993; 42():159-65. PubMed ID: 8356921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of nitric oxide, adrenergic activation and kinin-degradation in blood pressure homeostasis following an acute kinin-induced hypotension.
    Bjørnstad-Ostensen A; Berg T
    Br J Pharmacol; 1994 Dec; 113(4):1567-73. PubMed ID: 7889314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the kinin-generating cascade in enhanced vascular permeability in tumor tissue.
    Matsumura Y; Kimura M; Yamamoto T; Maeda H
    Jpn J Cancer Res; 1988 Dec; 79(12):1327-34. PubMed ID: 3148603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G Protein-Coupled Kinin Receptors and Immunity Against Pathogens.
    Scharfstein J; Ramos PIP; Barral-Netto M
    Adv Immunol; 2017; 136():29-84. PubMed ID: 28950949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hageman factor-dependent system in the vascular permeability reaction.
    Yamamoto T; Kozono K; Kambara T; Cochrane CG
    Biochim Biophys Acta; 1988 Aug; 966(2):196-206. PubMed ID: 3401504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger.
    Wu J; Akaike T; Maeda H
    Cancer Res; 1998 Jan; 58(1):159-65. PubMed ID: 9426072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kallikrein-kinin system in chronic subdural haematomas: its roles in vascular permeability and regulation of fibrinolysis and coagulation.
    Fujisawa H; Ito H; Kashiwagi S; Nomura S; Toyosawa M
    J Neurol Neurosurg Psychiatry; 1995 Oct; 59(4):388-94. PubMed ID: 7561918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hageman factor-dependent kinin activation in burns and its theoretical relationship to postburn immunosuppression syndrome and infection.
    Holder IA; Neely AN
    J Burn Care Rehabil; 1990; 11(6):496-503. PubMed ID: 2286602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triggering of the vascular permeability reaction by activation of the Hageman factor-prekallikrein system by house dust mite proteinase.
    Maruo K; Akaike T; Matsumura Y; Kohmoto S; Inada Y; Ono T; Arao T; Maeda H
    Biochim Biophys Acta; 1991 May; 1074(1):62-8. PubMed ID: 2043681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
    Kaplan AP
    Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of rabbit corpus cavernosum relaxation mediated by the tissue kallikrein-kinin system.
    Lopes-Martins RA; Antunes E; Oliva ML; Sampaio CA; Burton J; de Nucci G
    Br J Pharmacol; 1994 Sep; 113(1):81-6. PubMed ID: 7529116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
    Vianna RM; Calixto JB
    Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the plasma kallikrein-kinin system by Candida albicans proteinase.
    Kaminishi H; Tanaka M; Cho T; Maeda H; Hagihara Y
    Infect Immun; 1990 Jul; 58(7):2139-43. PubMed ID: 2194962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological enhancement of the kallikrein-kinin system promotes anti-fibrotic responses in human mesangial cells.
    Pawluczyk IZ; Patel SR; Harris KP
    Cell Physiol Biochem; 2006; 18(6):327-36. PubMed ID: 17170519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.